SOPHiA GENETICS SA (SOPH)
About SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $359.0M
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $359.0M
- Shares outstanding
- 62.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 23, 2021
SOPHiA GENETICS SA (SOPH) Stock Price
- Trading 12% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review SOPHiA GENETICS SA.
Write a review
News about SOPHiA GENETICS SA
News & sentiment via Polygon.io
SOPHiA GENETICS SA: frequently asked questions
Is SOPHiA GENETICS SA an American company?
SOPHiA GENETICS SA is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is SOPHiA GENETICS SA publicly traded?
Yes — SOPHiA GENETICS SA is a publicly traded company. Its stock trades under the ticker symbol SOPH on the NASDAQ.
What does SOPHiA GENETICS SA do?
SOPHiA GENETICS SA is an American Software company in the Technology & Electronics sector.
